1. Home
  2. RGEN vs GNRC Comparison

RGEN vs GNRC Comparison

Compare RGEN & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • GNRC
  • Stock Information
  • Founded
  • RGEN 1981
  • GNRC 1959
  • Country
  • RGEN United States
  • GNRC United States
  • Employees
  • RGEN N/A
  • GNRC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • GNRC Metal Fabrications
  • Sector
  • RGEN Health Care
  • GNRC Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • GNRC Nasdaq
  • Market Cap
  • RGEN 7.6B
  • GNRC 10.9B
  • IPO Year
  • RGEN N/A
  • GNRC 2010
  • Fundamental
  • Price
  • RGEN $156.55
  • GNRC $160.54
  • Analyst Decision
  • RGEN Buy
  • GNRC Buy
  • Analyst Count
  • RGEN 12
  • GNRC 20
  • Target Price
  • RGEN $187.44
  • GNRC $177.78
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • GNRC 665.9K
  • Earning Date
  • RGEN 02-19-2025
  • GNRC 02-12-2025
  • Dividend Yield
  • RGEN N/A
  • GNRC N/A
  • EPS Growth
  • RGEN N/A
  • GNRC 89.80
  • EPS
  • RGEN N/A
  • GNRC 4.82
  • Revenue
  • RGEN $633,513,000.00
  • GNRC $4,124,703,000.00
  • Revenue This Year
  • RGEN $2.28
  • GNRC $9.21
  • Revenue Next Year
  • RGEN $9.88
  • GNRC $8.29
  • P/E Ratio
  • RGEN N/A
  • GNRC $33.32
  • Revenue Growth
  • RGEN N/A
  • GNRC 2.91
  • 52 Week Low
  • RGEN $113.50
  • GNRC $108.89
  • 52 Week High
  • RGEN $211.13
  • GNRC $195.94
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • GNRC 44.08
  • Support Level
  • RGEN $149.15
  • GNRC $153.25
  • Resistance Level
  • RGEN $160.64
  • GNRC $162.17
  • Average True Range (ATR)
  • RGEN 5.96
  • GNRC 3.93
  • MACD
  • RGEN 0.91
  • GNRC 1.06
  • Stochastic Oscillator
  • RGEN 79.57
  • GNRC 76.61

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

Share on Social Networks: